Micro Emerging Active

HRTX 恶劣天气对外科手术的影响

新的叙述，覆盖范围有限 — 仍在形成中。

评分
0.4
动能
▲ 0.0
文章
2
来源
1

情绪时间线

事件时间线

五月 19, 2026
Why Heron Therapeutics, Inc. (HRTX) Price Target Was Reduced to $4 at … Bearish
五月 13, 2026
Heron Therapeutics, Inc. Q1 2026 Earnings Call Summary Neutral

假设

Pending 到期: 2026年10月10日

HRTX gross margin will compress by 150-250 basis points in Q1 2026 due to weather-related operational inefficiencies and fixed cost absorption over lower procedure volumes, with margin recovery of 100+ basis points by Q2 2026.

Pending 到期: 2026年8月11日

HRTX stock price will experience 5-15% downside within 10 trading days following Q1 2026 earnings announcement due to weather-related revenue miss and reduced guidance, followed by 8-12% recovery within 60 days as management provides mitigation strategy.

Pending 到期: 2026年9月10日

Severe weather impact on HRTX Q1 2026 surgical procedures will result in revenue decline of 8-12% compared to Q4 2025, with recovery expected by Q3 2026 as operational capacity normalizes.

相关文章

Why Heron Therapeutics, Inc. (HRTX) Price Target Was Reduced to $4 at H.C. Wainwright?

Yahoo Finance · 五月 19, 2026
Bearish

Heron Therapeutics, Inc. Q1 2026 Earnings Call Summary

Yahoo Finance · 五月 13, 2026
Mixed

时间线

最后更新五月 13, 2026